John B. Sanfilippo & Son
JBSS Nasdaq Packaged Foods & Meats Financials FY2017βFY2026
John B. Sanfilippo & Son's revenue rose 6.2% to $1.2 billion in fiscal 2026. Its operating margin was 7.6%, down from 7.7% a year earlier. Free cash flow was $36 million. It paid out $47 million in dividends and buybacks, 131% of free cash flow. The diluted share count rose 0.5%.
What John B. Sanfilippo & Son does
No business description yet.
- Legal name
- SANFILIPPO JOHN B & SON INC
- Fiscal year ends
- June 25, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-356919
0000880117
Revenue and margins
John B. Sanfilippo & Son had $1.2B of revenue in fiscal 2026, up 6.2% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 5.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $35.8M in fiscal 2026, 3.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
John B. Sanfilippo & Son returned $46.8M to shareholders in fiscal 2026, 131% of free cash flow. The diluted share count rose 0.5%.
Value John B. Sanfilippo & Son yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$48.5M and divides by 11.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 12.7x Β· peers 24.5x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably John B. Sanfilippo & Son can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.4M | $1.9M | $0.5M | $0.6M | $1.1M |
| Debt incl. finance leases | $10.9M | $7.8M | $7.1M | $15.5M | $49.6M |
| Net debt / EBITDA | 0.1x | 0.1x | 0.1x | 0.1x | 0.4x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| Interest coverage | 45.5x | 41.8x | 33.4x | 23.9x | 36.7x |
| Current ratio | 2.3x | 3.0x | 2.3x | 2.2x | 2.1x |
| Quick ratio | 0.6x | 1.0x | 0.8x | 0.6x | 0.6x |
| Total assets | $447M | $425M | $516M | $598M | $659M |
| Total liabilities | $168M | $133M | $193M | $237M | $279M |
| Shareholders' equity | $279M | $292M | $323M | $361M | $380M |
| Net debt (β = net cash) | $10.5M | $5.9M | $6.6M | $14.9M | $48.5M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.4M
4 insiders
Of sales under plans
100%
$1.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | James J SanfilippoDirector, 10% owner | Sold plan | 1,268 | $80.63 | $0.1M | Form 4 |
| Mar 2, 2026 | Jasper Brian Sanfilippo JrCOO, President, Director, 10% owner | Sold plan | 7,212 | $80.97 | $0.6M | Form 4 |
| Mar 2, 2026 | Jeffrey T SanfilippoChief Executive Officer, Director, 10% owner | Sold plan | 7,212 | $80.08 | $0.6M | Form 4 |
| Mar 2, 2026 | Lisa SanfilippoDirector, 10% owner | Sold plan | 2,272 | $81.43 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 2 / 9 | 3 / 9 |
| Accruals ratio | β8.8% | 5.1% | β9.9% |
| Altman Z'' | 6.19 | 5.85 | 5.32 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| John B. Sanfilippo & Son JBSS | $791M | 6.2% | 7.6% | 3.0% | 16.6% | β | 3 | |
| Freshpet FRPT | $3.6B | 13.0% | 6.9% | 1.1% | 5.9% | 16.9x | 8 | Compare β |
| Simply Good Foods SMPL | $936M | 9.0% | 10.8% | 10.9% | 6.1% | β | 4 | Compare β |
| J&J Snack Foods JJSF | $1.6B | 0.5% | 5.3% | 5.2% | 7.3% | 32.1x | 4 | Compare β |
| Tootsie Roll Industries TR | $2.6B | 1.3% | 13.8% | 13.2% | β | β | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $847M | $889M | $876M | $880M | $859M | $956M | $1,000M | $1.1B | $1.1B | $1.2B |
| Gross profit | $142M | $139M | $158M | $176M | $185M | $200M | $212M | $214M | $204M | $211M |
| Research and development | $0.7M | $0.7M | $0.9M | $1.0M | $2.0M | $2.8M | $3.4M | $3.6M | $3.5M | $3.3M |
| Operating income | $60.5M | $56.2M | $58.5M | $78.5M | $85.2M | $87.4M | $90.2M | $85.2M | $84.7M | $89.2M |
| Interest expense | $2.9M | $3.5M | $3.1M | $2.0M | $1.4M | $1.9M | $2.2M | $2.5M | $3.6M | $2.4M |
| Pretax income | $54.1M | $49.3M | $52.4M | $72.7M | $79.8M | $81.7M | $85.3M | $79.9M | $77.9M | $83.0M |
| Income tax | $18.0M | $16.8M | $13.0M | $18.6M | $20.1M | $19.9M | $22.5M | $19.7M | $18.9M | $21.0M |
| Net income | $36.1M | $32.5M | $39.5M | $54.1M | $59.7M | $61.8M | $62.9M | $60.2M | $58.9M | $61.9M |
| Diluted EPS | $3.17 | $2.84 | $3.43 | $4.69 | $5.17 | $5.33 | $5.40 | $5.15 | $5.03 | $5.26 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $52.7M | $66.2M | $83.5M | $63.6M | $105M | $19.6M | $125M | $102M | $30.5M | $124M |
| Capital expenditure | $10.9M | $13.2M | $15.1M | $15.0M | $25.2M | $17.8M | $20.7M | $28.3M | $50.7M | $88.1M |
| Free cash flow | $41.8M | $52.9M | $68.4M | $48.6M | $79.5M | $1.9M | $104M | $73.4M | β$20.2M | $35.8M |
| Depreciation and amortization | $15.6M | $15.4M | $17.0M | $17.9M | $18.3M | $18.3M | $20.5M | $24.6M | $26.9M | $28.2M |
| Stock-based compensation | $2.5M | $2.8M | $2.6M | $2.5M | $2.9M | $3.6M | $3.6M | $4.4M | $4.5M | $4.2M |
| Acquisitions | $0.0M | $21.7M | $0.0M | $0.0M | $0.0M | $0.0M | $3.5M | $59.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $56.5M | $28.4M | $29.1M | $68.7M | $57.5M | $34.5M | $54.9M | $34.8M | $24.4M | $46.8M |
| Dividends and buybacks | $56.5M | $28.4M | $29.1M | $68.7M | $57.5M | $34.5M | $54.9M | $34.8M | $24.4M | $46.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.0M | $1.4M | $1.6M | $1.5M | $0.7M | $0.4M | $1.9M | $0.5M | $0.6M | $1.1M |
| Total debt | $28.6M | $34.5M | $27.7M | $20.0M | $14.7M | $10.9M | $7.8M | $7.1M | $15.5M | $49.6M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $253M | $248M | $225M | $239M | $225M | $283M | $254M | $294M | $346M | $349M |
| Current liabilities | $110M | $117M | $83.9M | $112M | $100M | $123M | $85.7M | $126M | $156M | $168M |
| Inventory | $182M | $174M | $157M | $172M | $148M | $205M | $173M | $197M | $255M | $246M |
| Property and equipment, net | $126M | $125M | $126M | $124M | $133M | $133M | $136M | $165M | $178M | $256M |
| Total assets | $398M | $416M | $391M | $408M | $399M | $447M | $425M | $516M | $598M | $659M |
| Total liabilities | $163M | $173M | $137M | $169M | $156M | $168M | $133M | $193M | $237M | $279M |
| Shareholders' equity | $236M | $243M | $255M | $238M | $243M | $279M | $292M | $323M | $361M | $380M |
| Margins | ||||||||||
| Gross margin | 16.8% | 15.6% | 18.1% | 20.0% | 21.6% | 20.9% | 21.2% | 20.1% | 18.4% | 18.0% |
| Operating margin | 7.1% | 6.3% | 6.7% | 8.9% | 9.9% | 9.2% | 9.0% | 8.0% | 7.7% | 7.6% |
| EBITDA margin | 9.0% | 8.1% | 8.6% | 11.0% | 12.1% | 11.1% | 11.1% | 10.3% | 10.1% | 10.0% |
| Net margin | 4.3% | 3.7% | 4.5% | 6.2% | 7.0% | 6.5% | 6.3% | 5.7% | 5.3% | 5.3% |
| FCF margin | 4.9% | 6.0% | 7.8% | 5.5% | 9.3% | 0.2% | 10.4% | 6.9% | β1.8% | 3.0% |
| Returns | ||||||||||
| Return on capital | 14.9% | 13.8% | 15.8% | 21.8% | 24.8% | 24.2% | 22.6% | 20.5% | 18.2% | 16.6% |
| Return on capital employed | 20.3% | 19.2% | 19.3% | 26.1% | 28.7% | 28.1% | 27.2% | 23.4% | 20.4% | 19.1% |
| Return on equity | 14.9% | 13.6% | 15.9% | 22.0% | 24.9% | 23.7% | 22.0% | 19.6% | 17.3% | 16.7% |
| Return on assets | 9.2% | 8.0% | 9.8% | 13.6% | 14.8% | 14.6% | 14.4% | 12.8% | 10.6% | 9.9% |
| Growth | ||||||||||
| Revenue growth | β11.1% | 5.0% | β1.4% | 0.4% | β2.5% | 11.3% | 4.6% | 6.7% | 3.8% | 6.2% |
| Net income growth | 18.9% | β10.0% | 21.4% | 37.1% | 10.4% | 3.4% | 1.7% | β4.2% | β2.2% | 5.1% |
| EPS growth | 18.3% | β10.4% | 20.8% | 36.7% | 10.2% | 3.1% | 1.3% | β4.6% | β2.3% | 4.6% |
| FCF growth | β43.7% | 26.7% | 29.2% | β28.9% | 63.7% | β97.7% | 5,517.5% | β29.4% | β127.5% | β |
| Share count change | 0.6% | 0.4% | 0.5% | 0.3% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | 0.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.4x | 0.5x | 0.4x | 0.2x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.4x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| Interest coverage | 20.8x | 16.2x | 19.1x | 39.2x | 59.1x | 45.5x | 41.8x | 33.4x | 23.9x | 36.7x |
| Current ratio | 2.3x | 2.1x | 2.7x | 2.1x | 2.3x | 2.3x | 3.0x | 2.3x | 2.2x | 2.1x |
| Quick ratio | 0.7x | 0.6x | 0.8x | 0.6x | 0.8x | 0.6x | 1.0x | 0.8x | 0.6x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.3% | 1.5% | 1.7% | 1.7% | 2.9% | 1.9% | 2.1% | 2.7% | 4.6% | 7.5% |
| Stock comp / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Payouts / FCF | 135.1% | 53.6% | 42.5% | 141.5% | 72.3% | 1,866.7% | 52.9% | 47.4% | β | 130.8% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 4.0 | 7.0 | 7.0 | 7.0 | 6.0 | 6.0 | 6.0 | 2.0 | 3.0 |
| Altman Z'' | 5.9 | 5.4 | 6.5 | 5.8 | 6.2 | 6.5 | 7.6 | 6.2 | 5.9 | 5.3 |
| Accruals ratio | β4.2% | β8.3% | β10.9% | β2.4% | β11.2% | 10.0% | β14.2% | β8.8% | 5.1% | β9.9% |
Source: SEC EDGAR XBRL filings (CIK 0000880117). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.